1. Swissmedicinfo.
2. Drugs and lactation database, Lactmed.
3. Centre de référence sur les agents tératogènes de Paris . [cited ; Available from : www.lecrat.org].
4. Hale TW . Medications and mothers’ milk. 14 ed . Hale Publishing. 2010.
5. Schaefer C , Spielmann H , Vetter K , Weber-Schöndorfer C. Arzneimittel in Schwangerschaft und Stillzeit. 8 ed. Urban & Fischer Verlag/Elsevier GmbH. 2012.
6. Mygind H , Thulstrup AM , Pedersen L , Larsen H. Risk of intrauterine growth retardation, malformations and other birth outcomes in children after topical use of corticosteroid in pregnancy . Acta Obstet Gynecol Scand. 2002;81:234–9.
7. Jonville-Béra AP , Vial T. Médicaments et grossesse : prescrire et évaluer le risque. Elsevier Masson. 2012.
8. Briggs GG , Freeman RK , Yaffe SJ. Drugs in pregnancy and lactation : A reference guide to fetal and neonatal risk. 9th ed. Lippincott Williams & Wilkins (LWW). 2011.
9. Panchaud A , Csajka C , Merlob P , Schaefer C , Berlin M , De Santis M , et al. Pregnancy outcome following exposure to topical retinoids : A multicenter prospective study . J Clin Pharmacol. 2012;52:1844–51.
